BioRestorative Therapies, Inc. (BRTX)
$1.91+1.06%Close
SELLCRISIS · day 31
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $17M
- Beta
- 0.74
- P/E (TTM)
- -0.10
- Short % float
- 0.22%
- Days to cover
- 1.0
- SI change
- +13.5%
- 1W
- -10.75%
- 1M
- -30.80%
- vs SPY 1W
- -11.91%
- vs SPY 1M
- -33.79%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BRTX?
- LOPJLB’s latest quantitative signal on BioRestorative Therapies, Inc. (BRTX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BRTX in?
- BioRestorative Therapies, Inc. (BRTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does BioRestorative Therapies, Inc. (BRTX) do?
- BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy candidate is BRTX-100. This treatment involves cultu…